PATENT CLAIM ANALYSIS

Application Number: 15894397
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "001900"]

Abstract:
The present invention relates to reconstituted high density lipoprotein (rHDL) formulations comprising an apolipoprotein, a lipid and a lyophilization stabilizer. Said formulations have reduced renal toxicity and good long-term stability, especially in lyophilized form.

Claim (Index 72):
A method of preparing the rHDL formulation of  claim 54 , comprising preparing a mixture comprising the Apo A-I, phosphatidylcholine, and sodium cholate, treating the mixture to induce the formation of rHDL particles, and adding sucrose to obtain the rHDL formulation.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.14286
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14439094', '13803863', '15241895', '14633880', '13805488']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7606207544981084
- 35 USC 102 Novelty (BERT): 0.5916234683834485
- Combined Prediction Score: 0.7437210258866425
- Mean Citation Score: 391.685958
- Max Citation Score: 533.80524
- Similarity Product: 409.1456467014814

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test